ArticleCancers2022

Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).

Remedios Otero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.